Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Sildenafil Cream for FSAD
NCT04948151Phase 2Unknown
- Sponsor
- Strategic Science & Technologies
- Start
- Jun 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sildenafil in female sexual arousal disorder (FSAD), sponsored by Strategic Science & Technologies. Status: unknown.
02
Drugs
sildenafil
03
Conditions
female sexual arousal disorder (FSAD)
Beyond the preview
Go deeper on NCT04948151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04948151.